New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2013
07:13 EDTMDXGMiMedx is a top growth pick for 2014 at Canaccord
Canaccord named MiMedx a top growth pick for 2014 to reflect recent reimbursement changes, regulatory clarity on micronized products, Medtronic distribution agreement opportunity, and the positive coverage decision from the 6th MAC. Shares are Buy rated with a $12 price target raised from $8.
News For MDXG From The Last 14 Days
Check below for free stories on MDXG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2014
08:47 EDTMDXGMiMedx reports Q1 revenue slightly exceeded upper end of guidance
Q1 guidance was $18M-$19.5M. Q1 consensus of $19.09M. March revenue, in particular, grew significantly. The company expects a minimal amount of the confusion experienced in the first quarter will continue for a portion of the second quarter and then dissipate during the second quarter.
08:33 EDTMDXGMiMedx backs FY14 revenue $95M-$110M, consensus $99.67M
08:33 EDTMDXGMiMedx sees Q2 revenue $21.5M-$23.5M, consensus $19.09M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use